If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Total Voting Rights

30 Dec 2022 07:00

RNS Number : 6569K
Transense Technologies PLC
30 December 2022
 

30 December 2022

 

Transense Technologies plc

 ("Transense" or the "Company")

 

Total voting rights

 

Transense Technologies plc, the provider of specialist sensor systems, announces that the issued share capital of the Company at the date of this announcement comprises 16,437,740 ordinary shares of 10 pence ("Ordinary Shares"). The Company holds 604,027 Ordinary Shares in treasury and therefore, the total number of voting rights in the Company is 15,833,713.

 

The figure of 15,833,713 should be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Melvyn Segal (CFO)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter / George Payne (Corporate Finance)

Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper / Nick Rome

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

Notes to Editors:

 

Transense develops and supplies wireless sensor technology and systems. The Company has three business areas:

Transense is a developer of specialist wireless sensor systems used to enable real-time data gathering and monitoring. Products include the patent protected Surface Acoustic Wave (SAW) sensor technology, used to improve equipment power, performance, reliability and efficiency; iTrack, Transense 's Tyre Pressure Monitoring System, licensed to Bridgestone Corporation, the world's largest tyre producer, under a ten-year deal in June 2020; and a range of intelligent tyre monitoring equipment under the Translogik brand. Target sectors include aerospace, electric motors & drives, industrial machinery and performance automotive. 

The Company 's strategy is to maximise shareholder value through the delivery of sustained revenue growth from all three principal technologies - SAW, iTrack and Translogik probes - through leveraging excellence in innovation, know-how in commercialising technologies, industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. 

For further information please contact transense@walbrookpr.com or visit www.transense.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRZZMZZZZFGZZM
Date   Source Headline
1st Feb 20217:00 amRNSNotice of Results & Investor Presentation
28th Jan 20217:00 amRNSCompletion of Capital Reduction
21st Dec 20207:00 amRNSIssue of Options
17th Dec 20201:19 pmRNSResult of AGM
17th Dec 20207:00 amRNSAGM Update, new Website & Investor Presentation
9th Dec 20207:00 amRNSEstablishment of SAW Commercial Advisory Panel
23rd Nov 20207:00 amRNSPosting of Annual Report and Notice of AGM
6th Nov 20203:38 pmRNSDirector/PDMR Shareholding
22nd Oct 20208:45 amRNSHolding(s) in Company
20th Oct 202012:09 pmRNSDirector/PDMR Shareholding
20th Oct 20207:00 amRNSFinal results for the year ended 30 June 2020
19th Oct 20207:00 amRNSChange of Nomad and Broker & AIM Rule 17 update
12th Oct 20207:00 amRNSNotice of Results and Investor Presentation
10th Sep 20207:00 amRNSFinal consideration for iTrack transfer
25th Aug 202010:23 amRNSDirector/PDMR Shareholding
24th Aug 20209:27 amRNSHolding(s) in Company (Replacement)
20th Aug 20205:02 pmRNSHolding(s) in Company
8th Jul 20204:16 pmRNSDirector/PDMR Shareholding
7th Jul 20203:38 pmRNSHolding(s) in Company
3rd Jul 202011:30 amRNSHolding(s) in Company
3rd Jul 20207:00 amRNSInvestor Presentation
1st Jul 20206:12 pmRNSHolding(s) in Company
26th Jun 20201:54 pmRNSDirector/PDMR Shareholding
26th Jun 20207:00 amRNSGrant of Options/PDMR Dealing
25th Jun 20204:41 pmRNSDirector/PDMR Shareholding
25th Jun 20202:10 pmRNSDirector/PDMR Shareholding
25th Jun 20207:01 amRNSStrategic Update
25th Jun 20207:00 amRNSBridgestone Granted Worldwide iTrack Licence
12th Jun 202010:40 amRNSUpdate relating to the JCA with Bridgestone
1st Jun 20207:00 amRNSUpdate relating to the JCA with Bridgestone
5th May 20202:39 pmRNSHolding(s) in Company
1st May 20207:00 amRNSUpdate relating to the JCA with Bridgestone
16th Mar 20207:00 amRNSFurther Working Capital Loan Agreement
20th Feb 20207:00 amRNSInterim Results
20th Feb 20207:00 amRNSInterim Results
19th Feb 20207:00 amRNSChanges to Board responsibilities
13th Feb 20207:01 amRNSNotice of Interim Results
13th Feb 20207:00 amRNSExtension to Agreement with Bridgestone
19th Dec 20194:14 pmRNSResult of AGM
19th Dec 20197:00 amRNSAGM Statement
19th Nov 20197:00 amRNSNotice of AGM
15th Nov 20194:53 pmRNSHolding(s) in Company
7th Nov 20191:13 pmRNSHolding(s) in Company
26th Sep 20197:00 amRNSFinal results for the year ended 30 June 2019
14th Aug 20199:09 amRNSHolding(s) in Company
13th Aug 20192:45 pmRNSAwards of Options
13th Aug 20197:00 amRNSJoint Collaboration Agreement with Bridgestone
30th Jul 20197:00 amRNSTrading Update
1st Jul 201912:02 pmRNSHolding(s) in Company
30th Apr 20194:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.